252 related articles for article (PubMed ID: 19463925)
21. Effects of hydroxyl group numbers on the B-ring of 5,7-dihydroxyflavones on the differential inhibition of human CYP 1A and CYP1B1 enzymes.
Kim HJ; Lee SB; Park SK; Kim HM; Park YI; Dong MS
Arch Pharm Res; 2005 Oct; 28(10):1114-21. PubMed ID: 16276964
[TBL] [Abstract][Full Text] [Related]
22. Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelial cells: role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism.
Larsen MC; Angus WG; Brake PB; Eltom SE; Sukow KA; Jefcoate CR
Cancer Res; 1998 Jun; 58(11):2366-74. PubMed ID: 9622076
[TBL] [Abstract][Full Text] [Related]
23. Roles of NADPH-P450 reductase in the O-deethylation of 7-ethoxycoumarin by recombinant human cytochrome P450 1B1 variants in Escherichia coli.
Shimada T; Tsumura F; Gillam EM; Guengerich FP; Inoue K
Protein Expr Purif; 2000 Oct; 20(1):73-80. PubMed ID: 11035953
[TBL] [Abstract][Full Text] [Related]
24. Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1.
Doostdar H; Burke MD; Mayer RT
Toxicology; 2000 Apr; 144(1-3):31-8. PubMed ID: 10781868
[TBL] [Abstract][Full Text] [Related]
25. Effects of pomegranate chemical constituents/intestinal microbial metabolites on CYP1B1 in 22Rv1 prostate cancer cells.
Kasimsetty SG; Bialonska D; Reddy MK; Thornton C; Willett KL; Ferreira D
J Agric Food Chem; 2009 Nov; 57(22):10636-44. PubMed ID: 19919114
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons.
Shimada T; Guengerich FP
Chem Res Toxicol; 2006 Feb; 19(2):288-94. PubMed ID: 16485905
[TBL] [Abstract][Full Text] [Related]
27. Reverse type I binding spectra of human cytochrome P450 1B1 induced by flavonoid, stilbene, pyrene, naphthalene, phenanthrene, and biphenyl derivatives that inhibit catalytic activity: a structure-function relationship study.
Shimada T; Tanaka K; Takenaka S; Foroozesh MK; Murayama N; Yamazaki H; Guengerich FP; Komori M
Chem Res Toxicol; 2009 Jul; 22(7):1325-33. PubMed ID: 19563207
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of human recombinant cytochromes P450 CYP1A1 and CYP1B1 by trans-resveratrol methyl ethers.
Mikstacka R; Przybylska D; Rimando AM; Baer-Dubowska W
Mol Nutr Food Res; 2007 May; 51(5):517-24. PubMed ID: 17440990
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and evaluation of the inhibitory selectivity of novel trans-resveratrol analogues on human recombinant CYP1A1, CYP1A2 and CYP1B1.
Mikstacka R; Rimando AM; Dutkiewicz Z; Stefański T; Sobiak S
Bioorg Med Chem; 2012 Sep; 20(17):5117-26. PubMed ID: 22863525
[TBL] [Abstract][Full Text] [Related]
30. Further assessment of 17alpha-ethinyl estradiol as an inhibitor of different human cytochrome P450 forms in vitro.
Chang SY; Chen C; Yang Z; Rodrigues AD
Drug Metab Dispos; 2009 Aug; 37(8):1667-75. PubMed ID: 19454483
[TBL] [Abstract][Full Text] [Related]
31. Quantitative analysis of constitutive and 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced cytochrome P450 1B1 expression in human lymphocytes.
Spencer DL; Masten SA; Lanier KM; Yang X; Grassman JA; Miller CR; Sutter TR; Lucier GW; Walker NJ
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):139-46. PubMed ID: 10067811
[TBL] [Abstract][Full Text] [Related]
32. Expression of cytochrome P450 (CYP) enzymes in human nonpigmented ciliary epithelial cells: induction of CYP1B1 expression by TCDD.
Volotinen M; Mäenpää J; Kankuri E; Oksala O; Pelkonen O; Nakajima M; Yokoi T; Hakkola J
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3099-105. PubMed ID: 19324859
[TBL] [Abstract][Full Text] [Related]
33. Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2.
Chang TK; Chen J; Lee WB
J Pharmacol Exp Ther; 2001 Dec; 299(3):874-82. PubMed ID: 11714871
[TBL] [Abstract][Full Text] [Related]
34. Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.
Androutsopoulos VP; Papakyriakou A; Vourloumis D; Spandidos DA
Bioorg Med Chem; 2011 May; 19(9):2842-9. PubMed ID: 21482471
[TBL] [Abstract][Full Text] [Related]
35. 2,3,7,8-Tetrachlorodibenzo-p-dioxin modulates the induction of DNA strand breaks and poly(ADP-ribose) polymerase-1 activation by 17beta-estradiol in human breast carcinoma cells through alteration of CYP1A1 and CYP1B1 expression.
Lin PH; Lin CH; Huang CC; Fang JP; Chuang MC
Chem Res Toxicol; 2008 Jul; 21(7):1337-47. PubMed ID: 18558727
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin.
Chang TK; Chen J; Yang G; Yeung EY
J Pineal Res; 2010 Jan; 48(1):55-64. PubMed ID: 19919601
[TBL] [Abstract][Full Text] [Related]
37. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1.
Chang TK; Chen J; Yeung EY
Toxicol Appl Pharmacol; 2006 May; 213(1):18-26. PubMed ID: 16226778
[TBL] [Abstract][Full Text] [Related]
38. Effect of chlorinated hydrocarbons on expression of cytochrome P450 1A1, 1A2 and 1B1 and 2- and 4-hydroxylation of 17beta-estradiol in female Sprague-Dawley rats.
Badawi AF; Cavalieri EL; Rogan EG
Carcinogenesis; 2000 Aug; 21(8):1593-9. PubMed ID: 10910964
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of CYP1 by berberine, palmatine, and jatrorrhizine: selectivity, kinetic characterization, and molecular modeling.
Lo SN; Chang YP; Tsai KC; Chang CY; Wu TS; Ueng YF
Toxicol Appl Pharmacol; 2013 Nov; 272(3):671-80. PubMed ID: 23886934
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors.
Kim S; Ko H; Park JE; Jung S; Lee SK; Chun YJ
J Med Chem; 2002 Jan; 45(1):160-4. PubMed ID: 11754588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
